Cardinal Health Stock News

The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

Fourth quarter revenue was relatively flat at $60.2 billion; revenue increased 21% excluding the impact of a previously communicated contract expiration Fourth quarter GAAP1 operating earnings were $428 million and GAAP diluted EPS was $1.00 Fourth quarter non-GAAP operating earnings increased 19% to $719 million and non-GAAP diluted EPS increased 13% to $2.08 Fiscal Year 2025 adjusted free cas...

Drug distributor Cardinal Health said on Tuesday it would acquire Solaris Health for about $1.9 billion in cash.

Adds over 750 providers to Cardinal Health's multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the urology therapeutic area Cardinal Health MSO platforms reach ~3,000 providers in 32 states upon transaction close DUBLIN, Ohio , Aug. 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced tha...

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology are strategic growth drivers, outpacing traditional pharmaceutical markets and accelerating overall company growth. Recent urology acquisitions and strong specialty focus position Cardinal for abov...

Grant funds will also launch the development of Ohio's first statewide prescription drug repository DUBLIN, Ohio , July 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partne...

Div idend stocks ha ve long been a mainstay for investors focused on reliable returns and consistent income.

Key Points in This Article: Holding onto stocks that have significantly appreciated, rather than cashing out for short-term gains, preserves long-term portfolio growth and avoids capital gains taxes.